DI
BSX icon

DAGCO Inc’s Boston Scientific BSX Stock Holding History

DAGCO Inc’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-99
Closed -$6.21K – 148
2026
Q1 		$6.21K Hold
99
– – ﹤0.01% 300
2025
Q4 		$9.44K Hold
99
– – ﹤0.01% 287
2025
Q3 		$9.66K Hold
99
– – ﹤0.01% 276
2025
Q2 		$10.6K Hold
99
– – ﹤0.01% 263
2025
Q1 		$9.99K Buy
+99
New +$9.97K ﹤0.01% 244

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

DAGCO Inc's BSX Position: Q2 2026 in Review

DAGCO Inc sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 99 shares — an estimated $6.21K sold.

DAGCO Inc first reported a position in BSX in Q1 2025 and held it in 5 quarters. The position peaked at $10.6K in Q2 2025. 1,474 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • DAGCO Inc reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • DAGCO Inc sold 99 Boston Scientific shares in Q2 2026, an estimated $6.21K.
  • DAGCO Inc first reported a position in Boston Scientific in Q1 2025 and held it in 5 quarters.
  • DAGCO Inc's Boston Scientific position peaked at $10.6K in Q2 2025.
  • 1,474 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on DAGCO Inc's 13F filing for Q2 2026, filed 10 Jul 2026.